Much of the global pharmaceutical and biotech industry has yet to set any targets for reducing carbon emissions in line with the Paris Agreement, a new analysis has found, despite the biggest companies in the sector leading the way.
https://www.pharmalive.com/wp-content/uploads/2022/11/Reuterslab11-10-2022.jpg7991200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-09 15:53:062022-11-10 10:54:16Much of biopharma industry yet to set any climate impact targets – report